Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2892
Serum Level of KL-6, a Biomarker of Interstitial Lung Disease (ILD), Is Higher in Diffuse SSc Than in Limited SSc and RA Even When the Activity of ILD Is Low
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2347
Serum Levels of Resistin Are Associated with Synovial Inflammation and Knee Structural Changes in Patients with Symptomatic Knee Osteoarthritis
Osteoarthritis – Clinical Aspects - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2585
Serum MMP-3 and OPG As Predictors of Response to Traditional Dmards in a Treatment NaïVe Early Rheumatoid Arthritis Cohort
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2287
Serum Urate and Its Association with Endothelial Dysfunction in Young Adults
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2297
Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2158
Serum Uric Acid Is Positively Associated with Pulmonary Function in Korean Health Screening Examinees: A Cross-Sectional Study
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2408
Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88
Pediatric Rheumatology – Pathogenesis and Genetics - Poster- 9:00AM-11:00AM
-
Abstract Number: 2157
Share the Fate: Fibroblast-like Synoviocyte Cell-to-Cell Organelle Transfer Is Directed By the Inflammatory Microenvironment
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2477
Short Term Clinical Response to Initial Treatment with High Versus Low Dose Methotrexate in Mono- and Combination Therapy in Early Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2508
Significant Improvement of Rheumatoid Arthritis (RA) Outcome with Repeat Application of Disease Management (SSDM) Mobiles Tools: A Cohort Study of RA Patients in China
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2614
Similar Rates of Death, Serious Infections, Cancers, Major Cardiovascular Events in Patients Treated with Abatacept, Rituximab and Tocilizumab: Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2133
Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells
Biology and Pathology of Bone and Joint - Poster I- 9:00AM-11:00AM
-
Abstract Number: 2548
Single 1g Infusion Vs Double 1g Infusion of Rituximab in Rheumatoid Arthritis in a Large Teaching Hospital: Potential Clinical Benefits and Financial Savings
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2419
Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations